RBM-007 in Subjects witH ExudatIve Age-related Macular Degeneration

NCT03633084 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

9

Enrollment

INDUSTRY

Sponsor class

Conditions

Age-related Macular Degeneration

Interventions

DRUG: RBM-007 Injectable Solution

Sponsor

Ribomic USA Inc